| Active substance |
Isotretinoin
|
| Water Retention |
No
|
| Hepatotoxicity |
Moderate, requires periodic liver function tests
|
| Lab Test |
Liver function tests, lipid profiles, pregnancy tests
|
| Also known as |
13-cis-Retinoic acid
|
| Blood pressure |
No significant effect
|
| Trade name |
Accutane, Roaccutane, Claravis, others
|
| Storage conditions |
Store at controlled room temperature (15-30В°C), protect from light
|
| Chemical name |
(2Z,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid
|
| Formula |
C20H28O2
|
| Substance class |
Retinoid
|
| Main action |
Reduces sebum production, corrects abnormal keratinization, has anti-inflammatory properties
|
| Half-life |
10-20 hours
|
| Dosage (medical) |
Typically 0.5 to 1 mg per kg of body weight per day, taken in two divided doses
|
| Dosage (sports) |
Not applicable
|
| Effects |
Reduces acne, decreases sebum production, promotes skin renewal
|
| Side effects |
Dry skin, lips and eyes, itching, nosebleeds, muscle aches, sensitivity to sunlight, decreased night vision, potentially severe birth defects if taken during pregnancy
|
| Use in sports |
None
|
| Manufacturer |
DrogSun, Turkey
|
| Packing |
30 caps (20mg/cap)
|
|
There are no reviews yet.